Anthrax is a serious disease that can affect both animals and humans. It is caused by bacteria called Bacillus anthracis. People can get anthrax from contact with infected animals, wool, meat, or hides.Anthrax vaccine protects against anthrax disease. Anthrax vaccine was licensed in 1970.Based on limited but sound evidence, the vaccine protects against both cutaneous (skin) and inhalation anthrax.
Scope of the Report:
The classification of Anthrax Vaccines includes Live Vaccines and Cell free PA Vaccines, and the revenue proportion of Live Vaccines in 2016 is about 43%.
Anthrax Vaccines are widely used for human and animal. The most proportion of Anthrax Vaccines is used for animal, and the consumption proportion is about 95.1% in 2016.
South America region is the largest supplier of Anthrax Vaccines, with a production market share nearly 34.7% in 2016. Europe is the second largest supplier of Anthrax Vaccines, enjoying production market share nearly 17.6% in 2016.
South America is the largest sales place, with a sales market share nearly 39.3% in 2016. Following South America, Europe is the second largest sales place with the sales market share of 19.1%.
Along with the development of China 's Agricultural technology, there is a lot Chinese local manufacturer can produce Anthrax Vaccines, with the increasing demand, more and more manufactures will go into Anthrax Vaccines industry.
Market competition is intense. Emergent BioSolutions is the major manufacturer of Anthrax Vaccines used for human, Merial, Merck, Zoetis, Bayer Sanidad Animal,Colorado Serum, etc. are is t ...
Table of Contents
1 Market Overview
1.1 Anthrax Vaccines Introduction
1.2 Market Analysis by Type
1.2.1 Live Vaccines
1.2.2 Cell free PA Vaccines
1.3 Market Analysis by Applications
1.3.1 Human Use
1.3.2 Animal Use
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
220.127.116.11 United States Market States and Outlook (2014-2024)
18.104.22.168 Canada Market States and Outlook (2014-2024)
22.214.171.124 Mexico Market States and Outlook (2014-2024)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
126.96.36.199 Germany Market States and Outlook (2014-2024)
188.8.131.52 France Market States and Outlook (2014-2024)
184.108.40.206 UK Market States and Outlook (2014-2024)
220.127.116.11 Russia Market States and Outlook (2014-2024)
18.104.22.168 Italy Market States and Outlook (2014-2024)
1.4.3 Asia-Pacific (China, Japan, Korea, Ind ...